← Back to stories

FDA policy shifts on vaccines and flavored vapes under Trump administration

healthpoliticsSignificance: 6/10

The Facts

The FDA has authorized fruit-flavored vaping products for adults, marking a reversal from previous policies that aggressively regulated flavored vapes. The agency has also halted publication of studies on COVID and shingles vaccines. Robert F. Kennedy Jr. has announced federal efforts to limit overprescribing of psychiatric drugs including antidepressants.

How different outlets are framing this

The Washington Post frames these developments as significant policy reversals, emphasizing the shift in FDA approach and explicitly noting Trump's reported pressure on the FDA commissioner regarding vape authorization. Their coverage treats both the vaping policy change and the halting of vaccine studies as notable departures from previous practices, with the vaccine study story highlighting that the CDC had already decided not to publish a report showing COVID vaccine effectiveness in reducing hospitalizations.

CNN's coverage focuses specifically on RFK Jr.'s psychiatric drug initiative, framing it around his stated goal to curb 'overprescribing' - using his own terminology in the headline. CNN presents this as a proactive policy launch rather than a regulatory reversal, emphasizing the support for 'deprescribing' efforts. The outlet does not appear to be covering the vaping or vaccine study stories in the provided excerpt, suggesting different editorial priorities in terms of which aspects of the broader FDA policy shifts to highlight.

Source Articles